Award notice Supplies
Cbam 494/2025 janssen cilag/28
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Servicio Andaluz de Salud
Sevilla - Place of performance
- MÁLAGA
- Estimated value
- €353,000 excl. VAT
- Amount awarded
- €353,000 excl. VAT
- Planned end of contract
- 26 September 2027
likely re-tender around March 2027 - Bids received
- 1
- Procedure
- oth-single
- Publication
- 23 October 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC DE SEVILLA,CÓRDOBA Y MÁLAGA,MEDIANTE PROC.NEG.SIN PUBLIC.CON EMPRESA JANSSEN-CILAG,SA,TRAMITE URGENTE
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €350,000
- Median
- €846,164
- A quarter above
- €2,267,877
Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 734345-2026.